← back to search

Meiting Chen

University of Science and Technology of China · CN
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Cancer-related molecular mechanisms research, Advanced Breast Cancer Therapies, and Viral-associated cancers and disorders.
h-index
18
citations
1,422
works
118
NIH funding
primary concept
email

Recent publications

Prognostic index for predicting outcomes of trastuzumab deruxtecan in HER2 expressing metastatic breast cancer: a real-world multicenter study
The Oncologist 2025cited by 3position: lastdoi
Osteosclerotic changes on computed tomography predict disease progression and poor survival in prostate cancer with osteoblastic metastases
International Journal of Surgery 2025cited by 0position: firstdoi
Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance
The Oncologist 2024cited by 38position: firstdoi
Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis
Cell Communication and Signaling 2024cited by 36position: middledoi
A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer
Phytomedicine 2024cited by 13position: middledoi
A real‐world observation on thrombopoietic agents for patients with cancer treatment–induced thrombocytopenia in China: A multicenter, cross‐sectional study
Cancer 2024cited by 13position: firstdoi
N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation
Cellular & Molecular Biology Letters 2023cited by 47position: middledoi
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Cancer Immunology Immunotherapy 2023cited by 44position: firstdoi
Leukocyte-Specific Morrbid Promotes Leukocyte Differentiation and Atherogenesis
Research 2023cited by 13position: middledoi
Impact of Osteosclerotic Change on CT in Prostate Cancer with Osteoblastic Metastasis on Tumor Progression and Survival
SSRN Electronic Journal 2023cited by 0position: firstdoi
Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study
BMC Pulmonary Medicine 2022cited by 15position: firstdoi
HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activity
Cell Death and Disease 2021cited by 16position: middledoi
Treatment of pembrolizumab and chemotherapy results in pulmonary lymphoepithelioma-like carcinoma progression through harboring secondary amplification of PI3KCA and IL-7R
Lung Cancer 2020cited by 16position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Yanxia Shi · Chongqing Medical University5 papers (2023–2025)Riqing Huang · Sun Yat-sen University4 papers (2023–2025)Haifeng Li · Qingdao University3 papers (2023–2025)Cong Xue · Shandong First Medical University3 papers (2023–2025)Tongyu Lin · Creighton University2 papers (2020–2022)Rui-Ming Liu · Jiamusi University2 papers (2021–2023)Xiaojie Fang · Central Hospital of Zibo2 papers (2020–2022) · 2 papers (2023–2025)Zhenhua Yang · Guangzhou University of Chinese Medicine2 papers (2023–2025)Xiujiao Shen · Sun Yat-sen University2 papers (2024–2025)Fei Pan · Sun Yat-sen University Cancer Center2 papers (2024–2025)Shuai Yang · Harbin University of Science and Technology2 papers (2023–2025)Xin An · Hebei Agricultural University2 papers (2023–2024)Qixiang Rong · Sun Yat-sen University2 papers (2024–2025)Zheng Kuai · University of Alabama at Birmingham1 papers (2023–2023)Wanzi Hong · Southern Medical University1 papers (2023–2023)Yue Dong · Fudan University1 papers (2024–2024)Yuan Meng · Hebei Medical University1 papers (2020–2020)Yung‐Chang Chen · University of Electronic Science and Technology of China1 papers (2022–2022)Manming Cao · Southern Medical University1 papers (2023–2023)